RecruitingNCT06807840
Flu Infection at UPHS
Evaluating Immune Imprinting in the Context of Influenza Virus Infections
Sponsor
University of Pennsylvania
Enrollment
50 participants
Start Date
Jan 27, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Cellular and humoral immune responses in individuals with active influenza infection will be assessed. Each year, up to 50 participants will be enrolled. The investigators hypothesize that influenza infection will elicit mostly memory immune responses rather than de novo immune responses to infection.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Aged 18 years and older
- Influenza positive test result performed within the University of Pennsylvania Health System
Exclusion Criteria11
- Known latex allergy
- Immunosuppression as a result of an underlying illness or treatment with immunosuppressive or cytotoxic drugs, or use of anticancer chemotherapy or radiation therapy within the preceding 36 months
- Pregnancy due to the volume of blood collected in this study
- Treatment with immunoglobulin or another blood product within the 3 months prior to enrollment in this study
- Any neoplastic disease (excluding non-melanoma skin cancer or prostate cancer that is stable in the absence of therapy) or a history of any hematological malignancy ("active" is defined as having received treatment within the past 5 years)
- Known acute or chronic medical condition that, in the opinion of the investigator or appropriate sub-investigator, would interfere with the evaluation of immune responses
- Intends to donate blood during the study period
- A known human immunodeficiency virus, hepatitis B, or hepatitis C infection
- Any condition that would, in the opinion of the site investigator, place the subject at an unacceptable risk of injury or render the subject unable to meet the requirements of the protocol
- Prolonged inpatient hospitalization that disrupts or interferes with study procedures.
- Weigh less than 110lbs
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERinfluenza virus infection
Participants with active influenza virus infection will be enrolled in this study.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06807840
Related Trials
Clinical Trials of Quadrivalent Influenza Vaccine
NCT068245191 location
A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza
NCT056484484 locations
Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults
NCT051088181 location
Covid-19 and Influenza Oral Vaccine Study
NCT063552321 location
Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)
NCT066843791 location